Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Robins Chad M sold 120,595 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Apr 6 to Apr 8, 2026 · Filed Apr 8, 2026

From Apr 6 to Apr 8, 2026, Robins Chad M (Director, CEO and Chairman) sold 120,595 Adaptive Biotechnologies Corporation shares at an average US$14.65 for US$1.77M under a trading plan, leaving 2,180,518 shares. Filed Apr 8, 2026 (Form 4).

Sold
120,595 shares
Price
US$14.65 average (US$14.41 to US$15.19)
Value
US$1.77M
Holding after
2,180,518 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CEO and Chairman

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockSale83,332US$14.412,217,781Direct
Apr 8, 2026Common StockSale37,263US$15.192,180,518Direct

Source

View original at SEC

Related